Diagnos Stock Performance
| DGNOF Stock | USD 0.23 0.01 4.55% |
The firm owns a Beta (Systematic Risk) of -0.72, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning DIAGNOS are expected to decrease at a much lower rate. During the bear market, DIAGNOS is likely to outperform the market. At this point, DIAGNOS has a negative expected return of -0.0636%. Please make sure to confirm DIAGNOS's value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to decide if DIAGNOS performance from the past will be repeated at some future date.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days DIAGNOS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, DIAGNOS is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 359.4 K | |
| Total Cashflows From Investing Activities | 503.5 K | |
| Free Cash Flow | -2.1 M |
DIAGNOS |
DIAGNOS Relative Risk vs. Return Landscape
If you would invest 25.00 in DIAGNOS on October 30, 2025 and sell it today you would lose (2.00) from holding DIAGNOS or give up 8.0% of portfolio value over 90 days. DIAGNOS is currently producing negative expected returns and takes up 3.9038% volatility of returns over 90 trading days. Put another way, 35% of traded otc stocks are less volatile than DIAGNOS, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
DIAGNOS Target Price Odds to finish over Current Price
The tendency of DIAGNOS OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.23 | 90 days | 0.23 | about 50.0 |
Based on a normal probability distribution, the odds of DIAGNOS to move above the current price in 90 days from now is about 50.0 (This DIAGNOS probability density function shows the probability of DIAGNOS OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon DIAGNOS has a beta of -0.72 suggesting as returns on the benchmark increase, returns on holding DIAGNOS are expected to decrease at a much lower rate. During a bear market, however, DIAGNOS is likely to outperform the market. Additionally DIAGNOS has an alpha of 0.0557, implying that it can generate a 0.0557 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). DIAGNOS Price Density |
| Price |
Predictive Modules for DIAGNOS
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DIAGNOS. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.DIAGNOS Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. DIAGNOS is not an exception. The market had few large corrections towards the DIAGNOS's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold DIAGNOS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of DIAGNOS within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | -0.72 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.02 |
DIAGNOS Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of DIAGNOS for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for DIAGNOS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| DIAGNOS generated a negative expected return over the last 90 days | |
| DIAGNOS has some characteristics of a very speculative penny stock | |
| DIAGNOS has high historical volatility and very poor performance | |
| DIAGNOS has accumulated 831.58 K in total debt with debt to equity ratio (D/E) of 2.45, implying the company greatly relies on financing operations through barrowing. DIAGNOS has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist DIAGNOS until it has trouble settling it off, either with new capital or with free cash flow. So, DIAGNOS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DIAGNOS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DIAGNOS to invest in growth at high rates of return. When we think about DIAGNOS's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 438.83 K. Net Loss for the year was (2.61 M) with loss before overhead, payroll, taxes, and interest of (418.3 K). | |
| DIAGNOS has accumulated about 252.14 K in cash with (2.04 M) of positive cash flow from operations. | |
| Roughly 16.0% of DIAGNOS shares are held by company insiders | |
| Latest headline from news.google.com: MARPAI ANNOUNCES 2026 MOMENTUM and KEY PARTNERSHIP EXPANSION - marketscreener.com |
DIAGNOS Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of DIAGNOS OTC Stock often depends not only on the future outlook of the current and potential DIAGNOS's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. DIAGNOS's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 69.5 M | |
| Short Long Term Debt | 125 K | |
| Shares Float | 58.1 M |
DIAGNOS Fundamentals Growth
DIAGNOS OTC Stock prices reflect investors' perceptions of the future prospects and financial health of DIAGNOS, and DIAGNOS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DIAGNOS OTC Stock performance.
| Return On Equity | -24.52 | |||
| Return On Asset | -1.21 | |||
| Operating Margin | (4.06) % | |||
| Current Valuation | 12.4 M | |||
| Shares Outstanding | 69.47 M | |||
| Price To Earning | (4.08) X | |||
| Price To Book | 55.55 X | |||
| Price To Sales | 16.90 X | |||
| Revenue | 438.83 K | |||
| EBITDA | (2.45 M) | |||
| Cash And Equivalents | 252.14 K | |||
| Total Debt | 831.58 K | |||
| Debt To Equity | 2.45 % | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (2.04 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 1.54 M | |||
About DIAGNOS Performance
By analyzing DIAGNOS's fundamental ratios, stakeholders can gain valuable insights into DIAGNOS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DIAGNOS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DIAGNOS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company was founded in 1998 and is headquartered in Brossard, Canada. Diagnos operates under Health Information Services classification in the United States and is traded on OTC Exchange.Things to note about DIAGNOS performance evaluation
Checking the ongoing alerts about DIAGNOS for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for DIAGNOS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DIAGNOS generated a negative expected return over the last 90 days | |
| DIAGNOS has some characteristics of a very speculative penny stock | |
| DIAGNOS has high historical volatility and very poor performance | |
| DIAGNOS has accumulated 831.58 K in total debt with debt to equity ratio (D/E) of 2.45, implying the company greatly relies on financing operations through barrowing. DIAGNOS has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist DIAGNOS until it has trouble settling it off, either with new capital or with free cash flow. So, DIAGNOS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DIAGNOS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DIAGNOS to invest in growth at high rates of return. When we think about DIAGNOS's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 438.83 K. Net Loss for the year was (2.61 M) with loss before overhead, payroll, taxes, and interest of (418.3 K). | |
| DIAGNOS has accumulated about 252.14 K in cash with (2.04 M) of positive cash flow from operations. | |
| Roughly 16.0% of DIAGNOS shares are held by company insiders | |
| Latest headline from news.google.com: MARPAI ANNOUNCES 2026 MOMENTUM and KEY PARTNERSHIP EXPANSION - marketscreener.com |
- Analyzing DIAGNOS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DIAGNOS's stock is overvalued or undervalued compared to its peers.
- Examining DIAGNOS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DIAGNOS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DIAGNOS's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of DIAGNOS's otc stock. These opinions can provide insight into DIAGNOS's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DIAGNOS OTC Stock analysis
When running DIAGNOS's price analysis, check to measure DIAGNOS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIAGNOS is operating at the current time. Most of DIAGNOS's value examination focuses on studying past and present price action to predict the probability of DIAGNOS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIAGNOS's price. Additionally, you may evaluate how the addition of DIAGNOS to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets |